Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Assembly Biosciences Announces FDA Fast Track Designation for Chronic Hepatitis B Virus Treatment

americanpharmaceuticalreviewJuly 21, 2020

Tag: FDA , Assembly Biosciences , ABI-H2158 , HBV

PharmaSources Customer Service